X Bioscience (SET:XBIO) extended the deadline for selling its shares in Fruita Biomed to June 30, 2027, with the revised sale price reduced to 110 baht per share from 274.22 baht per share.

The company said the buyer's liquidity constraints and Fruita's weaker-than-expected performance prompted the changes, according to a Friday filing.

X Bioscience said it has recognized cumulative impairment losses of 270.6 million baht on the Fruita investment through the second quarter of 2026.